CN102935133B - 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 - Google Patents
一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN102935133B CN102935133B CN201210523876.5A CN201210523876A CN102935133B CN 102935133 B CN102935133 B CN 102935133B CN 201210523876 A CN201210523876 A CN 201210523876A CN 102935133 B CN102935133 B CN 102935133B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- rheumatic arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 201000003068 rheumatic fever Diseases 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000012567 medical material Substances 0.000 claims description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 235000011438 Albizia odoratissima Nutrition 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 241000545442 Radix Species 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 240000000559 Albizia odoratissima Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000157373 Uncaria rhynchophylla Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 239000013642 negative control Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 206010063560 Excessive granulation tissue Diseases 0.000 description 7
- 210000001126 granulation tissue Anatomy 0.000 description 7
- 235000009161 Espostoa lanata Nutrition 0.000 description 6
- 240000001624 Espostoa lanata Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 238000004064 recycling Methods 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000000114 Pain Threshold Diseases 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000037040 pain threshold Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 241000220433 Albizia Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229950005162 benexate Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- IAXUQWSLRKIRFR-SAABIXHNSA-N chembl2104696 Chemical compound C1C[C@@H](CNC(=N)N)CC[C@@H]1C(=O)OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IAXUQWSLRKIRFR-SAABIXHNSA-N 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210523876.5A CN102935133B (zh) | 2012-12-08 | 2012-12-08 | 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210523876.5A CN102935133B (zh) | 2012-12-08 | 2012-12-08 | 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102935133A CN102935133A (zh) | 2013-02-20 |
CN102935133B true CN102935133B (zh) | 2014-07-23 |
Family
ID=47694080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210523876.5A Expired - Fee Related CN102935133B (zh) | 2012-12-08 | 2012-12-08 | 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102935133B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800759A (zh) * | 2015-04-30 | 2015-07-29 | 淄博齐鼎立专利信息咨询有限公司 | 一种用于治疗风湿性关节炎的中药组合物 |
CN105296156A (zh) * | 2015-11-13 | 2016-02-03 | 李洋 | 一种樟木油香精的提取方法和应用 |
CN105663789A (zh) * | 2016-03-03 | 2016-06-15 | 冯字 | 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 |
CN107384643A (zh) * | 2017-09-01 | 2017-11-24 | 南京晶云化工有限公司 | 一种止痒香皂及其制备方法 |
CN115957260B (zh) * | 2022-10-26 | 2024-02-02 | 山西中医药大学 | 一种祛风湿抗炎的中药组合物及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009062301A (ja) * | 2007-09-05 | 2009-03-26 | Tropical Technology Center Ltd | ヤエヤマアオキエキスおよびその利用 |
CN101744895A (zh) * | 2008-12-03 | 2010-06-23 | 李国强 | 一种用于治疗风湿、腰颈椎病的药剂 |
CN101961477A (zh) * | 2009-07-22 | 2011-02-02 | 靳环杰 | 风湿骨疼灵 |
WO2012101741A1 (ja) * | 2011-01-24 | 2012-08-02 | 株式会社資生堂 | Tie2活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤 |
CN102302555A (zh) * | 2011-09-21 | 2012-01-04 | 中国人民解放军第二军医大学 | 一种治疗痛风性关节炎的中药提取物及其制备方法和应用 |
CN102657710A (zh) * | 2011-12-13 | 2012-09-12 | 吴新治 | 一种续筋骨治疗腰痛及腰椎间盘突出的药物及其制备方法 |
-
2012
- 2012-12-08 CN CN201210523876.5A patent/CN102935133B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102935133A (zh) | 2013-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101987123B (zh) | 一种用于缓解颈肩、腰腿、关节、肌肉疼痛的药物及其制备方法 | |
CN100384467C (zh) | 一种治疗肝炎和脂肪肝的中药组合物 | |
CN101987122A (zh) | 一种用于缓解人体疼痛的药物及其制备方法 | |
CN102935133B (zh) | 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 | |
CN101708297A (zh) | 一种治疗痛风病的药物 | |
CN103405582B (zh) | 改善类风湿关节炎关节肿痛的中药组合物 | |
CN104800759A (zh) | 一种用于治疗风湿性关节炎的中药组合物 | |
CN101129971B (zh) | 治疗妇女痛经、***的中药组合物及其制备方法 | |
CN102727753B (zh) | 一种用于治疗痛风的中药组合物及其制备方法和应用 | |
CN103127357B (zh) | 一种用于治疗肾结石的中药组合物及其制备方法和应用 | |
CN101912567B (zh) | 治疗慢性心肌炎的中药 | |
CN108543044B (zh) | 一种治疗痤疮的联合用药物及其用途 | |
CN1107338A (zh) | 浴用药酒 | |
CN102935195B (zh) | 一种用于治疗冠心病的中药组合物及其制备方法和应用 | |
CN102204978B (zh) | 一种治疗癌性疼痛的药物组合物及其制剂 | |
CN101129893A (zh) | 治疗颈椎病合并腹泻的中药 | |
CN101543577A (zh) | 一种治疗青春痘的中药组合及其制备方法 | |
CN104435567A (zh) | 一种含绞股蓝的治疗痛风的中药组合物 | |
CN104056177A (zh) | 一种治疗中耳炎的中药组合物 | |
CN102973820A (zh) | 一种治疗风湿性和类风湿性关节炎的中成药颗粒 | |
CN102228591A (zh) | 调经止痛的药物口服制剂的制备方法 | |
CN104306784A (zh) | 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 | |
CN100340272C (zh) | 一种治疗头痛的药物 | |
CN105663789A (zh) | 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 | |
CN108159150A (zh) | 一种治疗风湿痹症的中药组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GANSU MINXIAN KANGDA PHARMACEUTICAL DEVELOPMENT CO Free format text: FORMER OWNER: NANJING ZHENGKUAN PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. Effective date: 20140625 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Gan Dequan Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: GAN DEQUAN Free format text: CORRECT: ADDRESS; FROM: 211224 NANJING, JIANGSU PROVINCE TO: 748411 DINGXI, GANSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140625 Address after: 748411 Minxian Town, ten li, Dingxi, Gansu Applicant after: GANSU MINXIAN KANGDA PHARMACEUTICAL DEVELOPMENT CO., LTD. Address before: 211224 No. 1 Industrial Park, Jing Qiao Town, Lishui County, Jiangsu, Nanjing Applicant before: Nanjing Zhengkuan Pharmaceutical Science and Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 Termination date: 20161208 |